A DIAGNOSTIC KIT FOR USE IN THE DIAGNOSIS OF PHILADELPHIA CHROMOSOME-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

The invention is a diagnostic kit suitable for use in the diagnosis of Philadelphia-like acute lymphoblastic leukemia comprising the following genes; CD99, NOTCH1, EZH2, MPL, MLLT4, BCL2, IKZF2, FBXW7, CHD1, IRF8, IDH1, CD274, ETV6, IGJ, FLT3, CREBBP, EBF1, MLL, EPOR, JAK2, KDM6A, IRF4, IKZF3, JAK3,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TEZCAN ÜNLÜ, Havva, SEZGİN EVİM, Melike, ÜNAL, Ufuk, EFENDİ ERDEM, Ecem, ÇEÇENER, Gülşah, MERAL GÜNEŞ, Adalet, BAYTAN, Birol, EGELİ, Ünal
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention is a diagnostic kit suitable for use in the diagnosis of Philadelphia-like acute lymphoblastic leukemia comprising the following genes; CD99, NOTCH1, EZH2, MPL, MLLT4, BCL2, IKZF2, FBXW7, CHD1, IRF8, IDH1, CD274, ETV6, IGJ, FLT3, CREBBP, EBF1, MLL, EPOR, JAK2, KDM6A, IRF4, IKZF3, JAK3, KRAS, CRLF2, HOXA9, IL7R, ABL1, LMO1, FGFR1, NF1, IFITM1, CSF1R, CA6, IDH2, CTLA4, MUC4, IKZF1, JAK1, BCL6, AICDA, KLF2, MYC, BLNK, HOXA10, BCL11B, P2RY8, SEMA6A, SOCS1, PDCD1LG2, RUNX1, PTK2B, NUDT4, PAX5, SOCS2, PICALM, NTRK3, STIL, SH2B3, TLX3, TCF3, NRAS, WT1, TP53INP1, TAL1, PDGFRA, STAT3, PBX1, SETD2, NUP214, PDCD1, PAG1, PTPN1, PDGFRB, STAT5B, ABL2, DNM2, DNTT, LYL1, NT5C2, NUP98, PTPN11, GAPDH, RAG1, RAG2, SOX11, GPR110, TLX1, G6PD, TYK2, ZCCHC7, BCR, IFITM2, BRAF, ACTB, and the algorithm analysis in which the similarity is determined. L'invention concerne un kit de diagnostic approprié pour être utilisé dans le diagnostic de la leucémie lymphoblastique aiguë du type Philadelphie comprenant les gènes suivants : CD99, NOTCH1, EZH2, MPL, MLLT4, BCL2, IKZF2, FBXW7, CHD1, IRF8, IDH1, CD274, ETV6, IGJ, FLT3, CREBBP, EBF1, MLL, EPOR, JAK2, KDM6A, IRF4, IKZF3, JAK3, KRAS, CRLF2, HOXA9, IL7R, ABL1, LMO1, FGFR1, NF1, IFITM1, CSF1R, CA6, IDH2, CTLA4, MUC4, IKZF1, JAK1, BCL6, AICDA, KLF2, MYC, BLNK, HOXA10, BCL11B, P2RY8, SEMA6A, SOCS1, PDCD1LG2, RUNX1, PTK2B, NUDT4, PAX5, SOCS2, PICALM, NTRK3, STIL, SH2B3, TLX3, TCF3, NRAS, WT1, TP53INP1, TAL1, PDGFRA, STAT3, PBX1, SETD2, NUP214, PDCD1, PAG1, PTPN1, PDGFRB, STAT5B, ABL2, DNM2, DNTT, LYL1, NT5C2, NUP98, PTPN11, GAPDH, RAG1, RAG2, SOX11, GPR110, TLX1, G6PD, TYK2, ZCCHC7, BCR, IFITM2, BRAF, ACTB et l'analyse algorithmique dans laquelle la similarité est déterminée.